Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity

doi:10.3748/wjg.v24.i15.1601

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14042)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

1418

WORD

282

HTML

8396

Figures (1-5)

201

Tables (1-2)

192

Sum=10489

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

824

Download

516

Sum=1340

Publishing Process of This Article

Item

Count

Browse

1086

Download

1127

Sum=2213

Apr 21, 2018 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (58)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Apr 21, 2018; 24(15): 1601-1615
Published online Apr 21, 2018. doi: 10.3748/wjg.v24.i15.1601

Full Size Figure Download Figure

Figure 1 Brief description of OMICs signatures, including their main applications as biomarkers in clinical practice.

Citation: Pirola CJ, Sookoian S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J Gastroenterol 2018; 24(15): 1601-1615
URL: https://www.wjgnet.com/1007-9327/full/v24/i15/1601.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i15.1601